Timur Ivannikov
Stock Analyst at Cantor Fitzgerald
(0.62)
# 4,175
Out of 5,241 analysts
8
Total ratings
42.86%
Success rate
-14.39%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Timur Ivannikov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRQR ProQR Therapeutics | Reiterates: Overweight | $8 | $1.51 | +429.80% | 1 | Jun 27, 2025 | |
| PHVS Pharvaris | Maintains: Overweight | $28 → $25 | $28.81 | -13.22% | 1 | May 14, 2025 | |
| GOSS Gossamer Bio | Downgrades: Market Perform | $5 | $0.1927 | +2,494.71% | 2 | Mar 7, 2023 | |
| ANAB AnaptysBio | Downgrades: Market Perform | n/a | $58.74 | - | 1 | Jan 6, 2023 | |
| RCKT Rocket Pharmaceuticals | Initiates: Outperform | $22 | $3.07 | +616.61% | 1 | Jul 8, 2022 | |
| CBIO Crescent Biopharma | Downgrades: Market Perform | n/a | $18.55 | - | 2 | Nov 15, 2021 |
ProQR Therapeutics
Jun 27, 2025
Reiterates: Overweight
Price Target: $8
Current: $1.51
Upside: +429.80%
Pharvaris
May 14, 2025
Maintains: Overweight
Price Target: $28 → $25
Current: $28.81
Upside: -13.22%
Gossamer Bio
Mar 7, 2023
Downgrades: Market Perform
Price Target: $5
Current: $0.1927
Upside: +2,494.71%
AnaptysBio
Jan 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $58.74
Upside: -
Rocket Pharmaceuticals
Jul 8, 2022
Initiates: Outperform
Price Target: $22
Current: $3.07
Upside: +616.61%
Crescent Biopharma
Nov 15, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $18.55
Upside: -